Article
Radiomic signatures for the non-invasive prediction of EGFR mutation status in brain metastases of lung adenocarcinoma
2024-01-05
Abstract excerpt
The epidermal growth factor receptor (EGFR) mutation exists in approximately 50% of patients with lung adenocarcinoma and is crucial for predicting response to targeted therapies. An increasing number of patients with lung adenocarcinoma have brain metastases (BMs) at diagnosis or later develop BMs. The study aimed to establish a non-invasive radiomics model for distinguishing EGFR mutation status in BMs and inves...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 389cceee-7429-56aa-b566-651263bb4ba3
- DOI
- 10.21203/rs.3.rs-3831447/v1
